Introduction

This chapter focuses on the recognition and management of common adverse effects associated with clozapine treatment, particularly emphasizing serious conditions like clozapine-induced myocarditis. It discusses the importance of monitoring and effective strategies for addressing cardiac and metabolic adverse effects such as myocarditis, cardiomyopathy, tachycardia, orthostatic hypotension, and metabolic syndrome.